Rabbit Polyclonal GLYATL1 antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Fragment Protein within Human GLYATL1 aa 100-200.
View Alternative Names
GNAT, GLYATL1, Glycine N-acyltransferase-like protein 1, Acyl-CoA:glycine N-acyltransferase-like protein 1, Glutamine N-acyltransferase
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GLYATL1 antibody (AB187859)
Immunohistochemical analysis of paraffin-embedded Human kidney tissue labeling GLYALT1 with ab187859 at 1/500 dilution.
- WB
Supplier Data
Western blot - Anti-GLYATL1 antibody (AB187859)
All lanes:
Western blot - Anti-GLYATL1 antibody (ab187859) at 1/100 dilution
Lane 1:
RT-4 cell lysate
Lane 2:
U-251MG sp cell lysate
Lane 3:
Human plasma (IgG/HSA depleted) lysate
Lane 4:
Human liver tissue lysate
Predicted band size: 35 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The enzymatic action of GLYATL1 aids in the detoxification of metabolites by conjugating them to amino acids primarily glycine. It appears to function independently and is not known to form part of larger protein complexes. Its activity contributes to the reduction of potential toxicity from a variety of substrates helping to neutralize harmful compounds.
Pathways
Enzyme GLYATL1 plays a major role within the amino acid conjugation pathway which is part of phase II drug metabolism. It functions in concert with other detoxifying enzymes such as glycine N-acyltransferase (GLYAT) to bolster the liver's ability to process and eliminate xenobiotics. This pathway is critical for converting lipophilic substances into water-soluble products that can be excreted from the body.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Biomedicines 11: PubMed36672708
2023
Applications
Unspecified application
Species
Unspecified reactive species
American journal of translational research 13:10075-10093 PubMed34650682
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com